Clinical Trial Update: NUCALA® Special Drug Use Investigation (EGPA, Long-term)

View source ↗

Summary

This clinical trial update reports the completion and posting of long-term results for the NUCALA Special Drug Use Investigation in eosinophilic granulomatosis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Granulomatosis with Polyangiitis

Drugs mentioned

• Nucala (mepolizumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Churg-Strauss Syndrome, Eosinophilic Granulomatosis With Polyangiitis | Status: COMPLETED | Results posted: 2026-02-18